Related Experiment Video
Updated: Jan 22, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
VDR polymorphisms influence immunological response in HIV-1+ individuals undergoing antiretroviral therapy
Ronaldo Celerino da Silva1, Neyla Maria Pereira Alves1,2, Jorge José de Souza Pereira1,3
1Laboratorio de Immunopatologyia Keizo Asami (LIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Abstract:
Vitamin D exerts an immuno-modulatory activity on several immune system cells through the vitamin D receptor (VDR). Herein, we verified that age and a therapeutic regimen containing protease inhibitors are associated with failures in antiretroviral therapies (ARVs). In addition, we assessed whether a VDR SNP (rs11568820: C allele and CC genotype) and GC (rs2228570-rs11568820) allelic combinations are associated with immunological failure (p < 0.05). Our findings suggest a possible role of VDR SNPs on immunological failure in HIV-1+ individuals undergoing regular ARVs.
Insights
Vitamin D receptor (VDR) single nucleotide polymorphisms (SNPs) may influence treatment outcomes in HIV-1 patients. Specific VDR gene variations might be linked to immunological failure despite antiretroviral therapies (ARVs).
Area of Science:
- Immunology
- Genetics
- Virology
Background:
- Vitamin D modulates immune cell function via the vitamin D receptor (VDR).
- Age and protease inhibitor regimens can impact antiretroviral therapy (ART) effectiveness.
- Immunological failure in HIV-1 patients remains a significant clinical concern.
Purpose of the Study:
- To investigate the association between VDR single nucleotide polymorphisms (SNPs) and immunological failure in HIV-1-positive individuals.
- To explore the role of specific VDR SNPs (rs11568820) and their allelic combinations (GC, rs2228570-rs11568820) in treatment outcomes.
Main Methods:
- Retrospective analysis of HIV-1-positive patients undergoing ART.
- Genotyping for VDR SNPs, specifically rs11568820 (C allele, CC genotype).
- Assessment of GC allelic combinations (rs2228570-rs11568820) in relation to immunological failure.
Main Results:
- A statistically significant association (p < 0.05) was observed between VDR SNPs and immunological failure.
- The C allele and CC genotype of VDR SNP rs11568820 showed a potential link to treatment failure.
- Specific GC allelic combinations were also implicated in immunological outcomes.
Conclusions:
- VDR gene variations, including specific SNPs and allelic combinations, may play a role in determining immunological response to ART in HIV-1 patients.
- These genetic factors could contribute to treatment variability and immunological failure.
- Further research is warranted to elucidate the precise mechanisms and clinical implications of VDR SNPs in HIV-1 management.
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Impact of Individuals on Individuals
Single Nucleotide Polymorphisms-SNPs
Gene Therapy
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...

